Recruiting

High Resolution, High-speed Multimodal Ophthalmic Imaging

Knowledge of the pathogenesis of ocular conditions, a leading cause of blindness, has benefited greatly from recent advances in ophthalmic imaging. However, current clinical imaging systems are limited in resolution, speed, or access to certain structures of the eye. The use of a high-resolution imaging system improves the resolution of ophthalmoscopes by several orders of magnitude, allowing the visualization of many microstructures of the eye: photoreceptors, vessels, nerve bundles in the retina, cells and…

ClinicalTrials.gov IDNCT04129021
PhaseNA
Enrollment1200
SponsorCentre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Age18 Years
SexALL
I'm interested View official listing

Conditions studied

Retinitis Pigmentosa, Maculopathy, Age Related, Macular Dystrophy, Macular Edema, Retinal Detachment, Retinal Degeneration, Glaucoma, Vascular Inflammation, Hypertension, Stroke, Diabetes, Corneal Dystrophy, Keratoconus, Dry Eye, Trauma

About this study

Knowledge of the pathogenesis of ocular conditions, a leading cause of blindness, has benefited greatly from recent advances in ophthalmic imaging. However, current clinical imaging systems are limited in resolution, speed, or access to certain structures of the eye. The use of a high-resolution imaging system improves the resolution of ophthalmoscopes by several orders of magnitude, allowing the visualization of many microstructures of the eye: photoreceptors, vessels, nerve bundles in the retina, cells and nerves in the cornea. The use of a high-speed acquisition imaging system makes it possible to detect functional measurements such as the speed of blood flow. The combination of data from multiple imaging systems to obtain multimodal information is of great importance for improving the understanding of structural changes in the eye during a disease. The purpose of this project is to observe structures that are not detectable with routinely used systems.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * People over 18 * Patient with a pathology affecting the eye or healthy volunteer * Participant who signed the consent * Beneficiaries of the health insurance Exclusion Criteria: * Patients with a history of photosensitivity. * Patients who have just received a photodynamic therapy treatment ( * Patients taking drugs with photosensitivity as a side effect. * Persons with pacemakers or other implanted electronic medical device * Patients with viral conjunctivitis or any other infectious disease. * Patients with skin lesions on the neck or forehead * Patients at high risk of damage from optical radiation, such as aphakic patients, or patients with decreased sensitivity to light due to fundus disease. * Pregnant or lactating women * Participant unable to be followed throughout the study * Vulnerable people * Subjects with predisposition to closure of the iridocorneal angle

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.